comparemela.com

Latest Breaking News On - Nivolumab - Page 4 : comparemela.com

Injectable Opdivo 'Can Achieve the Same Goals' as IV Use in RCC

Subcutaneous administration of Opdivo, could increase efficiency and reduce wait times for patients, as one expert explains to CURE®.

Roswell-park
Saby-george
Drug-administration
Network-clinical-trials
University-of-buffalo
Biomedical-sciences
Jacobs-school-of-medicine
Roswell-park-comprehensive-cancer-center
Subcutaneous-opdivo
Jacobs-school
Subcutaneous-versus-intravenous

Dr Banerjee on Nivolumab Use After CAR T-Cell Therapy Progression in Myeloma and NHL

Rahul Banerjee, MD, FACP, discusses the use of nivolumab in multiple myeloma or non-Hodgkin lymphoma after progression following CAR T-cell therapy.

Rahul-banerjee
Fred-hutchinson-cancer-center
University-of-washington
Division-of-hematology
Clinical-research-division
Cellular-therapy
Cellular-therapy-meetings
D
Naacp
Nivolumab
Multiple-myeloma
Non-hodgkin-lymphoma

Long-Term Follow-Up from CheckMate 214 in Advanced RCC

The expert panel discusses the 8-year follow-up data from CheckMate 214 looking at nivolumab plus ipilimumab in first-line advanced RCC and provide clinical insights on treatment decisions.

Advanced-renal-cell-carcinoma
Term-follow-up
Renal-cell-carcinoma
Nrcc
Advanced-rcc
Checkmate-214
Nivolumab
Ipilimumab
Metastatic-clear-cell-rcc
Ctla4-inhibition
Ctla4

First-Line Treatments for Advanced Clear Cell RCC

A panel of medical oncologists who specialize in renal cell carcinoma (RCC) introduce themselves and discuss the first-line treatment landscape and risk stratification of clear cell RCC.

Advanced-renal-cell-carcinoma
Line-treatments
Advanced-clear-cell
Renal-cell-carcinoma
Nrcc
Advanced-rcc
Clear-cell-renal-carcinoma
Non-clear-cell-renal-carcinoma
Immunotherapy
Ipilimumab
Nivolumab

Dr Tripathi on the NEMIO Trial of Durvalumab Plus Chemo With/Without Tremelimumab in MIBC

Abhishek Tripathi, MD, discusses the phase 1/2 NEMIO trial of durvalumab/chemotherapy with/without tremelimumab in muscle-invasive bladder cancer.

Abhishek-tripathi
Onclive-tv
Urothelial-cancer
Hase-3-checkmate-901-trial
Nivolumab
Gemcitabine
Cisplatin

vimarsana © 2020. All Rights Reserved.